What is ABBV's current stock price?

As of now, ABBV is trading at $218.01, with a daily change of +0.87%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV

AbbVie

$218.01

+$1.86 | +0.87%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$244.81

MKT CAP

$384.98B

52W Low

$164.39

VOL

$3.87M

P/E Ratio

164.49

AVG VOL

$6.39M

RSI

43.40

TREND

Downtrend

ABBV Stock IQ

Login to see AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Target Price

Login to display

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Pays a reliable dividend

ABBV Price Performance

$228.8 (-4.72%)

$228.03 (-4.39%)

$207.92 (+4.85%)

$190.34 (+14.54%)

1year

6month

3month

1month

ABBV Analysts Opinion

ABBV overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABBV Analysts Opinion

ABBV Analysts opinion is positive but there was a setback from the past 3 months

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

0%

100%

ABBV Street Sentiment

ABBV Street Sentiment is bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

74%

17%

Positive

Negative

26 out of 35
events present

6 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$214.04

Resistance
Price

$213.76

Current Price Range

$234.30

Show methods +

Linked to ABBV

IQ

Close Price

Change

PFE

5.00

26.07

+0.75%

SNY

2.53

46.52

+0.73%

MRK

5.00

109.20

-1.76%

LLY

5.00

1087.89

+0.87%

NVS

4.93

145.01

-0.07%

Recently Viewed

Close Price

Change

ABBV

AbbVie

218.01

+0.87%

EHGO

Eshallgo Inc.

0.24

+3.60%

MTDR

Matador Resources Company

43.13

-1.39%

ALCO

Alico

40.72

-0.29%

MRNA

Moderna

51.88

+3.94%

ABBV Latest Analysis +

AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Wed Jan 14, 2026

$221.89 | +0.52%

Activity

Wall Street s Look Optimistic About AbbVie (ABBV): Should You Buy?. According to the average brokerage recommendation (ABR) one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Wed Jan 14, 2026

$221.89 | +0.52%

Potential

Ex-Dividend Reminder: AbbVie Dime Community Bancshares and MidWestOne Financial Group. Looking at the universe of stocks we cover at Dividend Channel on 1/16/26 AbbVie Inc (Symbol: ABBV) Dime Community Bancshares Inc (Symbol: DCOM) and MidWestOne Financial Group Inc. (Symbol: MOFG) will all trade ex-dividend for their respective upcoming dividends. AbbVie Inc

Wed Jan 14, 2026

$221.89 | +0.52%

Activity

Why AbbVie (ABBV) is a Top Value Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tue Jan 13, 2026

$220.75 | +0.32%

Potential

ABBV Inks Drug Pricing Deal With Trump Joins PD-1xVEGF Bandwagon. AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal cutting United States prices while expanding its oncology pipeline.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

Will AbbVies Oncology Segment Support Top-line Growth in Q4 Earnings?. ABBVs oncology unit is expected to post nearly 4% Q4 sales growth as newer drugs offset weakness from declining Imbruvica demand.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

AbbVie Commits $100 Bln To United States Innovation Pledges Lower Medicaid Drug Prices . (RTTNews) - AbbVie (ABBV) announced that it has entered into an agreement with the Trump administration aimed at expanding access and affordability for Americans while safeguarding and investing in United States pharmaceutical innovation.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans. AbbVie will provide low prices in Medicaid and expand affordable direct-to-patient offerings for treatments used by millions of Americans through TrumpRx AbbVie will commit $100 billion in United States research and development (R&D) and capital investments including manufacturing over the...

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

Potential

Abbvie reaches deal with Trump admin to cut drug prices invest $100 bln in US.

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors.

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

FAQ About ABBV Stock Insights

What is ABBV current stock price?

What are ABBV stock strengths?

What is ABBV Risk Level?

What is ABBV market cap and volume?

What is ABBV current Stock IQ?

Should I buy ABBV stock right now?

Is ABBV a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABBV?

What does a 'Strong Sell' rating mean for ABBV?

What factors influence ABBV's Stock IQ?

Explore our ABBV Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABBV Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABBV Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABBV

AbbVie

Set Alerts

Current Price

$218.01

+$1.86 | +0.87%

52W High

$244.81

MKT CAP

$384.98B

52W Low

$164.39

VOL

$3.87M

P/E Ratio

164.49

AVG VOL

$6.39M

RSI

43.40

TREND

Downtrend

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Stock Insights

Strengths

ABBV Rewards

Earnings are forecast to grow

ABBV Rewards

Trading below its fair value

ABBV Rewards

Upgraded on attractively valued

ABBV Rewards

Pays a reliable dividend

Linked to ABBV

Symbol

IQ

Close

Change

PFE

5.00

26.07

+0.75%

SNY

2.53

46.52

+0.73%

MRK

5.00

109.20

-1.76%

LLY

5.00

1087.89

+0.87%

NVS

4.93

145.01

-0.07%

ABBV Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

74%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

50%

0%

100%

ABBV Street Sentiment

ABBV Street Sentiment is bullish and have positive views on the near-term outlook

ABBV Risk Level

ABBV has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABBV Performance Sentiment

Sentiments overview associated with ABBV events and the stock performance.

74%

17%

Positive

Negative

26 out of 35
events present

6 out of 35
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$214.04

Resistance
Price

$213.76

Current Price Range

$234.30

Show methods +

Latest Analysts Recommendations

Date

Action

Rating

Firm

Jan 06, 2026

Price Target Raised

Buy

Morgan Stanley

Dec 13, 2025

Reiterate

Overweight

Morgan Stanley

Dec 11, 2025

Upgrade

on ABBV

Piper Sandler

Dec 10, 2025

Upgrade

Outperform

HSBC

Dec 10, 2025

Upgrade

Buy

HSBC

ABBV Stock IQ

Login to unlock AbbVie (ABBV) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABBV Latest Analysis

AbbVie Inc. (ABBV) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript.

Wed Jan 14, 2026

$221.89 | +0.52%

Activity

Wall Street s Look Optimistic About AbbVie (ABBV): Should You Buy?. According to the average brokerage recommendation (ABR) one should invest in AbbVie (ABBV). It is debatable whether this highly sought-after metric is effective because Wall Street analysts recommendations tend to be overly optimistic. Would it be worth investing in the stock?

Wed Jan 14, 2026

$221.89 | +0.52%

Potential

Ex-Dividend Reminder: AbbVie Dime Community Bancshares and MidWestOne Financial Group. Looking at the universe of stocks we cover at Dividend Channel on 1/16/26 AbbVie Inc (Symbol: ABBV) Dime Community Bancshares Inc (Symbol: DCOM) and MidWestOne Financial Group Inc. (Symbol: MOFG) will all trade ex-dividend for their respective upcoming dividends. AbbVie Inc

Wed Jan 14, 2026

$221.89 | +0.52%

Activity

Why AbbVie (ABBV) is a Top Value Stock for the Long-Term. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Tue Jan 13, 2026

$220.75 | +0.32%

Potential

ABBV Inks Drug Pricing Deal With Trump Joins PD-1xVEGF Bandwagon. AbbVie strikes a Trump drug-pricing pact and a $5.6B cancer licensing deal cutting United States prices while expanding its oncology pipeline.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

Will AbbVies Oncology Segment Support Top-line Growth in Q4 Earnings?. ABBVs oncology unit is expected to post nearly 4% Q4 sales growth as newer drugs offset weakness from declining Imbruvica demand.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

AbbVie Commits $100 Bln To United States Innovation Pledges Lower Medicaid Drug Prices . (RTTNews) - AbbVie (ABBV) announced that it has entered into an agreement with the Trump administration aimed at expanding access and affordability for Americans while safeguarding and investing in United States pharmaceutical innovation.

Tue Jan 13, 2026

$220.75 | +0.32%

Activity

AbbVie and Trump Administration Reach Agreement to Improve Access and Affordability for Americans. AbbVie will provide low prices in Medicaid and expand affordable direct-to-patient offerings for treatments used by millions of Americans through TrumpRx AbbVie will commit $100 billion in United States research and development (R&D) and capital investments including manufacturing over the...

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

Potential

Abbvie reaches deal with Trump admin to cut drug prices invest $100 bln in US.

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

AbbVie in up to $5.6B deal with RemeGen for bispecific antibody for solid tumors.

Mon Jan 12, 2026

$220.04 | +0.01%

Activity

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABBV. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABBV Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABBV Stock trends

ABBV Stock performance

ABBV Stock analysis

ABBV investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABBV

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ABBV Stock Analysis & IQ Rating | AbbVie

ABBV Stock IQ

ABBV Target Price

ABBV Analysts Opinion

ABBV Street Sentiment

ABBV Risk Level

ABBV Performance Sentiment

Technical Price Levels

Explore our ABBV Stock insights

Receive our ABBV Daily Alerts

ABBV Street Sentiment

ABBV Risk Level

Technical Price Levels

Latest Analysts Recommendations

Discover ABBV Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABBV. We're here to help you make informed investment decisions today.

Receive our ABBV Daily Alerts

ABBV Alerts